Rx only · Injection, Powder, Lyophilized, For Solution · Subcutaneous

Luspatercept

Brands: Reblozyl · Luspatercept

1 ACTIVE SUPPLIER — US

openFDA · updated weekly

US2 NDCs
1 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATCB03XA06

RxCUI (US)2262544

US makers1 labelers

Packages2

DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.8K

Rx · 2026 Q1

2.3K

Units dispensed

-25%

Rx vs. year ago

Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Celgene Corporation	unknown	2	SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.